Heme Oxygenase-1 Inhibits HLA Class I Antibody-Dependent Endothelial Cell Activation.
Antibody-mediated rejection (AMR) is a key limiting factor for long-term graft survival in solid organ transplantation. Human leukocyte antigen (HLA) class I (HLA I) antibodies (Abs) play a major role in the pathogenesis of AMR via their interactions with HLA molecules on vascular endothelial cells...
Main Authors: | Eva Zilian, Hendry Saragih, Vijith Vijayan, Oliver Hiller, Constanca Figueiredo, Abid Aljabri, Rainer Blasczyk, Gregor Theilmeier, Jan Ulrich Becker, Jan Larmann, Stephan Immenschuh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4686182?pdf=render |
Similar Items
-
TLR4 Signaling by Heme and the Role of Heme-Binding Blood Proteins
by: Sabina Janciauskiene, et al.
Published: (2020-08-01) -
Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy
by: Damaris A. Schillingmann, et al.
Published: (2019-01-01) -
Interplay of Heme with Macrophages in Homeostasis and Inflammation
by: Pooja Pradhan, et al.
Published: (2020-01-01) -
Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly?
by: Ditte M. S. Lundvig, et al.
Published: (2012-05-01) -
Targeting the Heme-Heme Oxygenase System to Prevent Severe Complications Following COVID-19 Infections
by: Frank A.D.T.G. Wagener, et al.
Published: (2020-06-01)